Print

Studying a Combination of Three Drugs to Treat Previously Untreated Metastatic Colorectal Cancer which Is MSI-High and Has a BRAF V600E Mutation

https://www.facingourrisk.org/research-clinical-trials/study/252/comparing-three-drugs-in-patients-with-metastatic-colorectal-cancer-who-have-not-had-prior-treatment

Clinicaltrials.gov identifier:
NCT05217446 (https://clinicaltrials.gov/show/NCT05217446)

Treatment
Study for metastatic colorectal cancer that has not yet been treated

Study Contact Information:

For additional information, please contact:

Pfizer CT.gov Call Center at 1-800-718-1021 or by email  clinicaltrials.gov_inquiries@pfizer.com


About the Study

This study is being done to learn about the effects of using three study medicines together as treatment for metastatic colorectal cancer that has been previously untreated.

What the Study Involves

Participants will be randomly selected (by chance) and placed into one of two groups. 

Study Sites

Arizona

California

Florida

Minnesota

New York

Tennessee

Texas

 


This Study is Open To:

Patients 16 years or older with metastatic colorectal cancer who:

 

This Study is Not Open To:

People who:

 


About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.